Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Benylin Mucus Cough

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Guaifenesin, Levomenthol may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Guaifenesin, Levomenthol

Equivalent medicines (same active substance, strength and form)

Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

How to take it

this medicine Check the table below to see how much medicine to take. ■ For oral use only. ■ Do not use more than the stated dose shown.

Children under 12 years Do not use in children under 12 years.

Adults and children aged 12 years and over AGE

DOSE

Adults and children aged Take Two 5 ml spoonfuls 12 years and over four times a day. Do not take more than 4 doses in 24 hours. If symptoms persist, talk to your doctor or pharmacist.

If anyone has too much If anyone has too much contact a doctor or your nearest Accident and Emergency Department (Casualty) taking this pack with you.

If you forget to take the medicine You should only take this medicine as required following the dosage instructions carefully. If you forget to take a dose, take the next dose when needed. Do not take a double dose.

125 ml

3 574661 694160 > LOT EXP

FPO BRAILLE PREVIEW

FRONT

BACK

Guaifenesin & Levomenthol ✓ Aids a productive cough

C h e s t Co n g

t ion

TM

es

es

c

✓ Thins and loosens chest mucus

benylin mucus cough

benylin mucus cough

COUGH

benylin mucus cough

MUCUS

Re d u

CHILD

Project Name / Design GB_Benylin Mucus Cough 125ml_Carton_Windsor_BV 3987

Not suitable for children under 12 years. Do not use more than

New Component / Item Code

XXXXXX

ArtWorks ID

EMEA_2022_00062512_000

Old Component / Item Code

N/A

Languages

English

Job / Version No.

402698645_r1

Date 31-01-2022

PANTONE 185 C

PANTONE 349 C

PANTONE 7435 C

Black

Varnish

FLEXO

FLEXO

FLEXO

FLEXO

–

REPRESENTATION:

125 ml

Colours represented with a diagonal line have been modified to aid PDF approval.

MANUFACTURING SITE Reference

ETQ014

Security Code / ICFP FPO

Substrate

White

Prefix : LOT EXP

LOT EXP

TECHNICAL DETAILS Component

Label

Plant

Delpharm Orléans

Dimensions

50 x 90 mm

Master Dieline

JJDEL_00060_V1

Date 12-05-2020

Profile

Text Limit

Bleed

Fold/Technical

Perforation

Stamping Area

Coding (Silent Zone)

Print & Varnish Free

Print Free

Varnish Free

Seal Area

Tamper Evident Label Area

Braille Grid

2022-01-24 14:51:31

Gotham-Bold Gotham-Medium GothamNarrow-Bold GothamNarrow-Medium

Smallest Text Size 6.5pt

Ave. Text Size 6.5pt

Largest Text Size 13.39pt

LOT

EXP

Product / Eurocode / Mat. ID Code XXXXXX

MUCUS

Fonts used

CHILD

Project Name / Design GB_Benylin Mucus Cough 125ml_Label_ROEP_3513

XXXXXXXX

This is a FPO non-drowsy formulation. 4 doses in 24 hours. Do not store above Do not exceed the stated dose. As with all similar medicines, if you 30°C. Store in the original container. Do not use if are pregnant or breast-feeding, consult your doctor or pharmacist bottle seal is broken when COUGH purchased. Keep out of the before taking this product. sight and reach of children. Please consult your doctor or Guaifenesin & Marketing Authorisation pharmacist if symptoms persist. Levomenthol holder: McNeil Products CONTENTS: Each 5 ml of cough Ltd, High Wycombe, syrup contains: Guaifenesin 100 mg, DOSE: For oral use Buckinghamshire, Levomenthol 1.1 mg. only. Adults and HP12 4EG, UK. children aged 12 Also contains: Liquid glucose, years and over: sucrose, ethanol, sodium, E124, E211. PL 15513/0056 Benylin is a registered trade Two 5 ml spoonfuls Please read the outer carton mark. four times a day. carefully before use and retain it for future reference.

Possible side effects

Date 01-06-2020

Stamping Area

Perforation

Seal Area

Tamper Evident Label Area

Like all medicines, this medicine can cause side-effects, although not everybody gets them. If you experience any of the following stop using the medicine and seek medical help immediately: ■ Allergic reactions including skin rashes (which may be severe and include blistering and peeling of the skin) and itching. Other effects that may occur include: ■ Nausea, vomiting, stomach pain or diarrhoea. Reporting of side-effects If you experience any side-effects, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed here. You can also report side-effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side-effects, you can help provide more information on the safety of this medicine.

1. What the medicine is for Benylin Mucus Cough is a medicine which is used to help relieve chesty coughs. It contains Guaifenesin (an expectorant) to help loosen mucus (phlegm) from the lungs and make it easier to cough up, and Levomenthol to help you breathe more easily by easing congestion.

MUCUS COUGH

5. Storing this medicine

Interstate-LightCondensed

SMALLEST TEXT SIZE

4.00 pt AVE. TEXT SIZE

7 pt LARGEST TEXT SIZE

34.18 pt

Guaifenesin & Levomenthol ✓ Aids a productive cough ✓ Thins and loosens chest mucus

6. Further information: What's in this medicine?

TM

UK Only

C h e s t Co n g

t ion

What the medicine looks like Benylin Mucus Cough is a clear red syrup, available in a 125 ml glass bottle.

es

es

The active ingredients in 5 ml of Benylin Mucus Cough are: 100 mg Guaifenesin and 1.1 mg Levomenthol. Other ingredients are: Sucrose, liquid glucose, ethanol, glycerol, sodium citrate, saccharin sodium, citric acid monohydrate, sodium benzoate (E211), Ponceau 4R (E124), caramel (E150), carbomer, raspberry essence, natural sweetness enhancer and water.

c

FONTS USED Gotham-Black Gotham-Bold Gotham-Medium GothamCondensed-Bold GothamCondensed-Medium GothamNarrow-Black PharmaBrailleUKReg ZapfDingbatsITC

Do not store this product above 30°C. Store in the original container. Do not use if bottle seal is broken when purchased. Keep the product out of the sight and reach of children. Do not use your medicine after the date shown as an expiry date on the packaging. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. Retain carton for full instructions.

Re d u

Braille Grid

The medicine is for use in adults and children aged 12 years and over.

2. Before taking this medicine This medicine is suitable for most people, but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist.

Do not use this medicine If you have ever had a bad reaction to any of the ingredients. ■ For a child under 12 years of age. ■

If any of these apply to you, get advice from a doctor or pharmacist without using Benylin Mucus Cough.

Talk to your doctor or pharmacist If you suffer from liver or kidney problems. ■ If you have been told by your doctor that you have an intolerance to some sugars. ■ If you have had a cough for a few weeks that may be caused by asthma, or a cough which brings up a lot of mucus (phlegm). ■ If you are taking alcohol. If you are not sure about any of the medicines you are taking, show the bottle or pack to your pharmacist. If any of these bullet points apply to you now or in the past, talk to a doctor or pharmacist. Marketing Authorisation holder: McNeil Products Ltd, High Wycombe, HP12 4EG, UK. Manufacturer: Delpharm Orléans, 5 avenue de Concyr, 45071 Orleans, Cedex 2, France. PL 15513/0056 This carton was revised in January 2024. Recycling information: Carton and leaflet: recycle. Bottle: rinse, cap on, recycle. Benylin is a registered trade mark. McNeil Products Limited 2024 © ■

If you are pregnant or breast-feeding ■

Ask your doctor or pharmacist for advice before taking this medicine if you are pregnant or breast-feeding.

Some of the ingredients can cause problems Contains 3.5 g of glucose and 1 g of sucrose per 5 ml. This should be taken into account in patients with diabetes mellitus. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. ■ This medicine contains 197 mg of alcohol (ethanol) in each 5 ml. The amount in 5 ml of this medicine is equivalent to less than 5 ml beer or 2 ml wine. The small amount of alcohol in this medicine will not have any noticeable effects. ■ This product contains Ponceau 4R (E124) red colouring which may cause allergic reactions. ■ This medicine contains 16.43 mg sodium (main component of cooking/table salt) in each 5 ml. This is equivalent to 0.82% of the recommended maximum daily dietary intake of sodium for an adult. ■ This medicine contains 10 mg sodium benzoate (E211) in each 5 ml. ■

Frequently asked questions about Benylin Mucus Cough

What is the active substance in Benylin Mucus Cough?

The active substance in Benylin Mucus Cough is guaifenesin, levomenthol.

Are there equivalent medicines to Benylin Mucus Cough?

Medicines with the same active substance, strength and form include: Benylin Chesty Coughs (Non-Drowsy). They are interchangeable only if your prescriber or pharmacist says so.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Benylin Mucus Cough, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Benylin Mucus Cough without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Guaifenesin (30 medicines), Guaifenesin, levomenthol (2 medicines), Levomenthol (13 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

BENYLIN Chesty Coughs (Non-drowsy) is indicated for the symptomatic relief of cough.

4.2. Posology and method of administration

Adults and children aged 12 years and over:

Oral. Two 5 ml spoonfuls four times a day.

Children under 12 years:

This product is contraindicated in children under the age of 12 years (see section 4.3).

The Elderly:

As for adults.

Hepatic/renal dysfunction

Experience with the use of this product suggests that normal adult dosage is appropriate for mild to moderate dysfunction. Caution should be exercised in severe hepatic and severe renal impairment. [See Pharmacokinetics].

Do not exceed the stated dose.

Keep out of the sight and reach of children.

4.3. Contraindications

This product is contraindicated in individuals with known hypersensitivity to the product, or any of its components.

Not to be used in children under the age of 12 years.

4.4. Special warnings and precautions for use

This product should not be used for persistent or chronic cough, such as occurs with asthma, or where cough is accompanied by excessive secretions, unless directed by a physician.

Caution should be exercised when using the product in the presence of severe renal or severe hepatic impairment, [See Pharmacokinetics].

Contains 3.5 g of glucose and 1 g of sucrose per 5 ml. This should be taken into account in patients with diabetes mellitus.

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

This medicine contains 197 mg of alcohol (ethanol) in each 5 ml. The amount in 5 ml of this medicine is equivalent to less than 5 ml beer or 2 ml wine. The small amount of alcohol in this medicine will not have any noticeable effects.

This medicinal product contains 16.43 mg sodium per 5 ml, equivalent to 0.82% of the WHO recommended maximum daily intake of 2 g sodium for an adult.

This medicine contains 10 mg sodium benzoate (E 211) in each 5 ml.

This product contains Ponceau 4R (E 124) red colouring which may cause allergic reactions.

4.5. Interaction with other medicinal products and other forms of interaction

If urine is collected within 24 hours of a dose of this product a metabolite of guaifenesin may cause a colour interference with laboratory determinations of urinary 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).

4.6. Fertility, pregnancy and lactation

Pregnancy

There are no or limited amount of data from the use of Guaifenesin in pregnant women. Animal studies are insufficient with respect to reproductive toxicity (see section 5.3). Insufficient information is available on the effects of administration of this product during human pregnancy. This product is not recommended during pregnancy and in women of childbearing potential not using contraception

Breastfeeding

Guaifenesin is excreted in breast milk in small amounts. There is insufficient information on the effects of Guaifenesin in newborns/infants. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from this product, taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.

Fertility

There is insufficient information available to determine whether guaifenesin has the potential to impair fertility.

4.7. Effects on ability to drive and use machines

This product has no or negligible influence on the ability to drive or operate machinery.

4.8. Undesirable effects

The safety of guaifenesin/menthol is based on available data from clinical trials and adverse drug reactions (ADRs) identified during post-marketing experience are included.

The frequencies are provided according to the following convention:

Very common ≥1/10

Common ≥1/100 and < 1/10

Uncommon ≥1/1,000 and <1/100

Rare ≥1/10,000 and <1/1,000

Very rare <1/10,000, including isolated reports

Not known (cannot be estimated from the available data)

ADRs are presented for frequency category based on 1) incidence in adequately designed clinical trials or epidemiology studies if available or 2) when incidence cannot be estimated, frequency category is listed as 'Not known'

Adverse Drug Reactions identified During Clinical trials, Epidemiology studies and Post-Marketing Experience with Guaifenesin. Frequency Category Estimated from Clinical Trials or Epidemiology Studies.

Body system

Incidence

Reported adverse event

Immune System Disorders

Not known

Hypersensitivity reactions (hypersensitivity, pruritus and urticaria)

Rash

Gastrointestinal Disorders

Not known

Abdominal pain upper

Diarrhoea

Nausea

Vomiting

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Symptoms and signs

The effects of acute toxicity from guaifenesin may include gastro-intestinal discomfort, nausea and drowsiness.

When taken in excess, guaifenesin may cause renal calculi.

Treatment

Treatment should be symptomatic and supportive.

💬 Ask about this leaflet

Ask anything about Benylin Mucus Cough. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Medicines containing Guaifenesin, Levomenthol

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →